Bramshill Investments, LLC Atea Pharmaceuticals, Inc. Transaction History

Bramshill Investments, LLC

  • $905 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$7.67 - $44.59 $43,956 - $255,545
-5,731 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$21.33 - $35.06 $122,242 - $200,928
5,731 New
5,731 $201,000
Q1 2021

May 17, 2021
SELL
$41.42 - $88.44 $307,170 - $655,871
-7,416 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$26.36 - $41.78 $195,485 - $309,840
7,416 New
7,416 $310,000

Others Institutions Holding AVIR

# of Institutions
110
Shares Held
53.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $248M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Bramshill Investments, LLC Portfolio

Follow Bramshill Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bramshill Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bramshill Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email